Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition
Guardant Health Inc. (NASDAQ:GH) is one of the best cancer stocks to invest in now. On February 23, Guardant Health Inc. (NASDAQ:GH) completed the acquisition of the health technology company MetaSight Diagnostics. The $149 million acquisition comes as the company gears up for revenue growth in 2026.
With the acquisition, Guardant Health is to gain access to a range of next-generation liquid biopsies designed for the early detection of chronic and acute diseases, including cancer. Guardant is handing over $59 million in advance payments and has pledged up to $90 million in potential regulatory and commercial milestone payments.
MetaSight has carved a niche in developing next-generation diagnostics platforms using computational biology and advanced data analysis to identify disease signals in blood samples. Its acquisition will help strengthen Guardant Health’s research pipeline and expand its precision medicine capabilities.
The acquisition comes when Guardant Health is experiencing robust revenue growth with total revenue soaring 33% year over year in 2025 to $982 million. The increase was driven by growth in the oncology division, where revenue was up 26% to $683.6 million. For 2026, the company projects revenue growth of 27% to 30%, to a range of $1.25 billion to $1.28 billion.
Guardant Health, Inc. (NASDAQ:GH) is a precision oncology company that develops liquid biopsy-based tests to detect cancer early, monitor recurrence, and guide personalized treatment selection. It provides comprehensive, non-invasive genomic profiling for patients with advanced or early-stage cancer.
While we acknowledge the potential of GH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 13 Best Manufacturing Stocks to Invest In Now and 11 AI Stocks That Will Go to the Moon.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ripple Partner Reaches One Million People With Safe Water
NASDAQ TRADE HALT CONTINUES <UCFIW.O> REASON NOT AVAILABLE AT 03:58 AM
VIPCross-Asset Positioning Amid AI Earnings Scrutiny and the US Election
1. Markets diverged during the week. Between the October 23 and October 30 closes, BTC fell 4.78%, the Nasdaq 100 declined 1.98%, and gold and silver dropped 2.72% and 8.59%, respectively. The DAX, KOSPI, Nikkei 225 and Hang Seng advanced. We focus on differences in growth prospects, valuation sensitivity and risk exposures rather than applying a single directional view across assets. 2. Market reactions to Alphabet's and Intel's earnings brought returns on AI investment into focus. Attention is shifting from the scale of capital expenditure to revenue realization, margins and free cash flow. Lower interest rates can ease discount-rate pressure, but a sustained valuation recovery still requires support from both operating performance and financing conditions. 3. The November 3 US midterm elections and November 6 employment report are key events in the coming week. We monitor how post-election fiscal and legislative agendas may affect interest rates, the dollar and industry operating conditions. Our execution priorities are to manage leverage and concentration, retain margin and exit-liquidity buffers, and avoid treating a single political outcome as an automatic trading signal. 4. Following Binance's disclosure of a security incident, industry attention to endpoint protection, access segregation and coordinated incident response has increased. Key assets to monitor: BTC, the Nasdaq 100, crude oil and gold, alongside upcoming earnings from AAPL, AMD, PLTR, ARM, ANET and QCOM.
HYATT HOTELS CORP <H.N>: JEFFERIES RAISES TARGET PRICE TO $188 FROM $167
Crypto prices
More
